American Well (AMWL)
NYSE Market Open
American Well Corporation, known commercially as Amwell, is a healthcare technology company focused on enabling digital and hybrid care delivery for large healthcare organizations. Its customers include health systems, insurers, employers, and other healthcare enterprises that need secure, scalable tools for connecting patients with clinicians across virtual and in-person settings.
The company’s core offering is the Amwell Platform, a cloud-based software environment designed to support telehealth visits, virtual primary care, urgent care, behavioral health programs, specialty care, and other digital care workflows. The platform helps organizations manage scheduling, patient intake, video consultations, clinical documentation, prescribing, referrals, and access to care programs from a centralized system. For providers, the technology is intended to fit into established clinical routines rather than operate as a standalone consumer app.
Amwell also supports clients with services that help them design and operate hybrid care strategies. These can include implementation work, workflow configuration, program management, and access to licensed clinical staffing where appropriate. This services component is important because many hospitals and payers need operational support as well as software when moving more care interactions online.
The company operates in a competitive digital health market shaped by demand for convenient access, cost control, clinician efficiency, and broader use of remote care after the expansion of telemedicine. Amwell’s positioning is enterprise-oriented: it sells infrastructure that healthcare institutions can use under their own care models, rather than relying primarily on a direct-to-consumer healthcare brand.
Last updated
- Market Cap
- 142.02M
- P/E
- —
- P/FCF
- —
- P/S
- 0.6
- Enterprise Value
- -37.18M
- Sector
- Industrials
- Industry
- Business Services, Not Elsewhere Classified
- Address
- 75 STATE STREET, Boston, MA, 02109
Online Mental Health Counseling Market worth USD 8,763.1 Million by 2032 - Exclusive Report by Coherent Market Insights
Global Electronic Health Record Market is Projected to Reach ~USD 54 Billion by 2032 | DelveInsight
U.S. Virtual Care Market Insights Report 2025-2034: Revenues to Grow Exponentially, Reaching $69.2 Billion by 2034 at 29.2% CAGR
Amwell® divests virtual psychiatric care business to Avel eCare in all-cash transaction
Patient Engagement Solutions Market to hit USD 84.6 billion by 2032, says Global Market Insights Inc.
Online Doctor Consultation Market Size to Hit USD 68.23 Billion by 2033 | Straits Research
Telehealth Market to Reach $851.0 Billion, Globally, by 2032 at 25.7% CAGR: Allied Market Research
At 23.3% CAGR, Telehealth and Telemedicine Market Share Will be Worth USD 813.7 Billion by 2034 - GlobeNewswire
Amwell Announces Reverse Stock Split
Amwell Announces Appointment of Ricky Goldwasser to its Board of Directors
Amwell Co-Founder Roy Schoenberg Becomes Executive Vice Chairman of the Board
Amwell CEO Roy Schoenberg to Speak at Stanford Disability & Telehealth Conference
Compared to Estimates, American Well (AMWL) Q1 Earnings: A Look at Key Metrics
American Well Corporation (AMWL) Reports Q1 Loss, Misses Revenue Estimates
Amwell® to Report First Quarter 2024 Operating Results May 1
Amwell Receives Continued Listing Standard Notice From NYSE
Power of Amwell Hybrid Care Solutions to be Highlighted at HIMSS 2024
Amwell Names Cynthia Horner, M.D., Chief Medical Officer
Amwell to Participate in Upcoming Investor Conference
American Well Corporation (AMWL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 142.02M
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- -37.18M
- P/E
P/E ratio compares a company's share price to its earnings per share.
- —
- P/B
P/B ratio compares a company's share price to its book value per share.
- 0.62
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 0.6
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 0.64
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- -0.16
- EPS
- -5.26
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- —
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- —
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- -41.85M
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- -38.66%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- -26.96%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 3.08
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 3.07
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 2.14
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 81.09K
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 8.5
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 54.88M | 55.31M | 56.29M | 70.9M | 66.83M |
| Gross profit | 27.96M | 28.34M | 29.51M | 39.76M | 35.26M |
| Operating income | -17.42M | -25.15M | -29.33M | -20.38M | -30.41M |
| EBITDA | -9.83M | -16.66M | -21.66M | -10.39M | -22.61M |
| Net income | -10.89M | -24.92M | -32.38M | -19.7M | -18.7M |
| Basic EPS | -0.66 | -1.52 | -2 | -1.24 | -1.19 |
| Diluted EPS | -0.66 | -1.52 | -2 | -1.24 | -1.19 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 325.97M | 323.79M | 359.43M | 388.66M | 419.47M |
| Total liabilities | 85.85M | 76M | 92.06M | 94.08M | 113.69M |
| Total equity | 240.12M | 247.79M | 267.36M | 294.57M | 305.77M |
| Cash & equivalents | 179.21M | 182.33M | 200.89M | 219.07M | 222.41M |
| Current assets | 258.26M | 246.68M | 271.17M | 289.65M | 311.5M |
| Current liabilities | 83.77M | 73.21M | 86.49M | 87.92M | 106.73M |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | -983K | -17.36M | -18.77M | -4.72M | -25.11M |
| Investing cash flow | -2.79M | -2.29M | 0 | 0 | 19.39M |
| Financing cash flow | 303K | -1K | 299K | -1K | 543K |
| Change in cash | -3.12M | -18.56M | -18.18M | -3.34M | -5.91M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 144 — American Well Corp | View Filing | |
| edgar index | 144 — American Well Corp | View Filing | |
| edgar index | SCHEDULE 13G/A — American Well Corp | View Filing | |
| edgar index | 8-K — American Well Corp | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | SCHEDULE 13G/A — American Well Corp | View Filing | |
| edgar index | 4 — American Well Corp | View Filing | |
| form 4 | Form 4 — Schoenberg Ido | View Filing | |
| form 4 | Form 4 — Schoenberg Ido | View Filing | |
| edgar index | 8-K — American Well Corp | View Filing | |
| edgar index | 10-Q — American Well Corp | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | DEF 14A — American Well Corp | View Filing | |
| edgar index | DEFA14A — American Well Corp | View Filing | |
| edgar index | ARS — American Well Corp | View Filing | |
| edgar index | 8-K — American Well Corp | View Filing | |
| edgar index | 4 — American Well Corp | View Filing | |
| edgar index | 4 — American Well Corp | View Filing | |
| edgar index | 4 — American Well Corp | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 144 — American Well Corp | View Filing | |
| edgar index | 144 — American Well Corp | View Filing | |
| form 4 | Form 4 — McNeice Paul Francis | View Filing | |
| form 4 | Form 4 — Zamansky Dmitry | View Filing | |
| form 4 | Form 4 — Gotlib Phyllis | View Filing | |
| form 4 | Form 4 — Gotlib Phyllis | View Filing | |
| edgar index | 4 — American Well Corp | View Filing | |
| edgar index | 4 — American Well Corp | View Filing | |
| edgar index | 4 — American Well Corp | View Filing | |
| edgar index | 4 — American Well Corp | View Filing | |
| edgar index | S-8 — American Well Corp | View Filing | |
| form 4 | Form 4 — McNeice Paul Francis | View Filing | |
| form 4 | Form 4 — Zamansky Dmitry | View Filing | |
| form 4 | Form 4 — Gotlib Phyllis | View Filing | |
| form 4 | Form 4 — Gotlib Phyllis | View Filing | |
| form 4 | Form 4 — HIRSCHHORN MARK | View Filing | |
| edgar index | 4 — American Well Corp | View Filing | |
| edgar index | 4 — American Well Corp | View Filing | |
| edgar index | 4 — American Well Corp | View Filing | |
| edgar index | 4 — American Well Corp | View Filing | |
| edgar index | 144 — American Well Corp | View Filing | |
| edgar index | 144 — American Well Corp | View Filing | |
| edgar index | 144 — American Well Corp | View Filing | |
| form 4 | Form 4 — McNeice Paul Francis | View Filing | |
| form 4 | Form 4 — Gotlib Phyllis | View Filing | |
| form 4 | Form 4 — HIRSCHHORN MARK | View Filing | |
| form 4 | Form 4 — Zamansky Dmitry | View Filing | |
| edgar index | SCHEDULE 13G/A — American Well Corp | View Filing | |
| edgar index | SCHEDULE 13G/A — American Well Corp | View Filing | |
| edgar index | 8-K — American Well Corp | View Filing | |
| edgar index | 10-K — American Well Corp | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — mda | View Filing | |
| ten k section | 10-K — risk_factors | View Filing | |
| edgar index | SCHEDULE 13G — American Well Corp | View Filing | |
| edgar index | 8-K — American Well Corp | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — American Well Corp | View Filing | |
| edgar index | 4 — American Well Corp | View Filing | |
| edgar index | 4 — American Well Corp | View Filing | |
| edgar index | 144 — American Well Corp | View Filing | |
| edgar index | 144 — American Well Corp | View Filing | |
| edgar index | 8-K — American Well Corp | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — McNeice Paul Francis | View Filing | |
| form 4 | Form 4 — Gotlib Phyllis | View Filing | |
| form 4 | Form 4 — Gotlib Phyllis | View Filing | |
| form 4 | Form 4 — Zamansky Dmitry | View Filing | |
| edgar index | 4 — American Well Corp | View Filing | |
| form 4 | Form 4 — Jackson Deborah C | View Filing | |
| form 4 | Form 4 — Jackson Deborah C | View Filing | |
| form 4 | Form 4 — Jackson Deborah C | View Filing | |
| edgar index | 4 — American Well Corp | View Filing | |
| edgar index | 4 — American Well Corp | View Filing |